Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen IncfiledCriticalAmgen Inc
Publication of AR026766A1publicationCriticalpatent/AR026766A1/en
Polipéptidos similares a interferon y moléculas de ácido nucleico que los codifican. Se provee agentes selectivos de enlace, vectores, células huésped ymétodos para producir polipéptidos similares a interferon. La presente provee adicionalmente compo siciones farmacéuticas y métodos para el diagnostico,tratamiento, mejora y/o prvencion de enfermedades, desordenes y condiciones asociadas con polipéptidos similares a interferon.Interferon-like polypeptides and nucleic acid molecules that encode them. Selective binding agents, vectors, host cells and methods are provided to produce interferon-like polypeptides. The present further provides pharmaceutical compositions and methods for the diagnosis, treatment, improvement and / or prevention of diseases, disorders and conditions associated with interferon-like polypeptides.
ARP000106547A1999-12-082000-12-11
MOLECULES SIMILAR TO INTERFERON AND USES OF THE SAME
AR026766A1
(en)
DERIVATIVES OF PIPERAZINE, PROCEDURES TO PREPARE THEM, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, THEIR USE AS A MEDICINAL PRODUCT AND THE METHOD FOR TREATING DISEASES MEDIATED BY TACHININ.
[6,7-Dihydro-5h-imidazole [1,2-alpha] imadazol-3-sulfonyl mino] propionamide derivatives, pharmaceutical composition, use thereof, and process for their preparation